Connect with us

Hi, what are you looking for?

Online Business Success

Thailand to launch mass coronavirus vaccination drive as cases surge

Thailand will launch its Covid-19 immunisation programme on Monday, focused mostly on the Oxford/AstraZeneca jab produced at Siam Bioscience, a company owned by King Maha Vajiralongkorn that has never previously produced a vaccine.

The rollout is a high-stakes one for both Prayuth Chan-ocha’s government, which faces growing anger from the public and business over delays in making vaccines available, and AstraZeneca, which chose Thailand as its south-east Asian production hub.

Siam Bioscience will produce 200m doses of the coronavirus jab, including for export.

Thailand is contending with a surge in infections of about 2,000-4,000 reported new cases a day — the highest since the start of the pandemic.

Like its regional peers Vietnam and Taiwan, the kingdom brought reported Covid-19 infections down to zero in 2020. The spike in cases has been blamed on more contagious variants of the coronavirus that have spread quickly through markets, prisons and worker camps.

But there have been signs of delays in production at Siam Bioscience. The Philippines said last week a first batch of 17m doses it was expecting from Thailand had been delayed and reduced in size.

Separately, Thailand’s Rural Doctors Society has alleged the government was importing 500,000 doses of the AstraZeneca vaccine from South Korea to make up for a production shortfall. Some Thais have reported being told they could expect vaccination appointments in June only to be advised later that they had been postponed.

Advertisement. Scroll to continue reading.

The Thai government last week received delivery of 1.8m doses of the jab from AstraZeneca, the first of 6m vaccines scheduled to arrive this month. It insists the rollout is on schedule but a government spokesman declined to respond to a question from the Financial Times about whether it would be using imported jabs from South Korea alongside locally made ones. Siam Bioscience declined to comment and AstraZeneca’s Thai office did not respond to a request for comment.

The Thai Enquirer, an outspoken online publication, last week called Siam Bioscience an “international embarrassment”.

“Even the Serum Institute in India is having problems, so it would be wrong to expect everything with first-time producer Siam Bioscience to go as smooth as silk,” said Pavida Pananond, professor of international business at Thammasat Business School, referring to the Indian vaccine manufacturer. “But AstraZeneca could do a lot by being more upfront.”

As infections surged early this year, the Thai government was accused of relying too much on a single vaccine made at a first-time vaccine producer. More recently, it has moved to shore up supplies of jabs from alternative suppliers including Sinovac, the Chinese pharmaceutical company, BioNTech/Pfizer, and Johnson & Johnson, the US drugmaker.

Thais’ freedom to criticise Siam Bioscience has been constrained by the fact that the billionaire king owns it, and making remarks deemed insulting to the royal family is a criminal offence.

Thanathorn Juangroongruangkit, Thailand’s most prominent opposition figure, was charged with lese-majesty and “computer crimes” in January after online comments about what he called the “royal vaccine”.

The 69-year-old Thai king’s power and wealth came under unusual criticism from participants in last year’s youth-led democracy protests.

Additional reporting by Ryn Jirenuwat in Bangkok

Follow on Twitter: @JohnReedwrites

Advertisement. Scroll to continue reading.

Latest coronavirus news 05b8 4e93 931f 4d6c213dcd60

Follow FT’s live coverage and analysis of the global pandemic and the rapidly evolving economic crisis here.

Source link

Click to comment

Leave a Reply


Loan And Finance

Earlier this week, Angel Risk Management – which specialises in underwriting products for the small to medium-sized sector on behalf of AXA XL –...

Loan And Finance

Sony Music Entertainment’s RCA Records has launched its first Asia division in Greater China. The new label will focus on signing artists in the...

Top Stories

The top financial officials from the Group of Seven (G7) largest advanced industrial economies has called on the Financial Stability Board to speed up...

Loan And Finance

Continued progress and trading momentum across Life and General Insurance Strong and resilient capital position, with capital return to be completed by end of...

Online Business Success

Making hybrid work environments work Photo by CoWomen on Unsplash Over the past two years, the workplace has evolved from forced remote work to...

Top Stories

The Society for Worldwide Interbank Financial Telecommunication, or SWIFT, the Belgian financial messaging network used by banks in international money transfers, announced Thursday that...


You May Also Like


Introductions get a lot of attention. I’ve explored the topic of how to write them even though as a reader, I always skip them....

SEO Guide

There are all kinds of pictures of the world on the internet, but to find one of these specific pictures that you want to...

Online Business Success

The internet is now our nervous system. We are constantly streaming and buying and watching and liking, our brains locked into the global information...

Online Business Success

You can think of link building in many ways. I like to call it tedious, painful, and a test of patience. It’s also necessary...